Dollar Tree received and sold over-the-counter drugs produced by foreign drugmakers that routinely violated federal law, according to a Nov. 14 warning letter from the FDA.
Pharmacy
All brand-name drugmakers could collectively lose more than $1 trillion and the pharmaceutical industry would still be the most profitable sector, according to an analysis published Nov. 14 by West Health Policy Center and Johns Hopkins Bloomberg School of Public…
A breakthrough therapy to treat certain advanced blood cancers, known as chimeric antigen receptor T-cell therapy, has shown promising results — even complete remissions in some patients — but its costs aren't sustainable for hospitals, which stand to lose hundreds…
As the traditional pharmacy industry gets increasingly difficult to navigate, two of the largest retail pharmacy chains in the U.S. are trying new and starkly different approaches to remain afloat.
Bridgewater, N.J.-based Amneal Pharmaceuticals is the latest company to recall its ranitidine products after discovering they contain unacceptable levels of a possible carcinogen.
Advertisement
The World Health Organization said Nov. 13 that it will begin a prequalification program to test and approve generic versions of insulin to lower costs and improve access around the world.
Mylan said Nov. 12 that when it merges with Pfizer's Upjohn unit, the combined company will be called Viatris.
Miles White, the longtime CEO of Abbott Laboratories will step down as chief executive in March 2020, according to The Wall Street Journal.
Teva Pharmaceuticals will resume producing the vital cancer drug vincristine after a shortage caused a "nightmare situation" for physicians and patients, according to STAT.
Researchers are warning of a possible prolonged shortage of the vital blood-thinning drug heparin, which is made from pig intestines, as African Swine Fever is wiping out a quarter of the world's pigs, according to Bloomberg.